16 June 2022EMAImlygic: adverse event;quality defectAdverse event;Quality defectMedicine safety communications
13 June 2022EMADefitelio: lack of effect;safety signalLack of effect;Safety signalMedicine safety communications
5 May 2022EMARubraca: referral - article 20 procedureReferral - Article 20 procedureMedicine safety communications
7 March 2022EMARemicade / Flixabi / Inflectra / Remsima / Zessly: new contraindicationNew contraindicationMedicine safety communications
18 December 2021EMABriviact (in Italy: Nubriveo): quality defectQuality defectMedicine safety communications
13 October 2021EMAJcovden (previously COVID-19 Vaccine Janssen): safety signalSafety signalMedicine safety communications
13 October 2021EMAVaxzevria (previously COVID-19 Vaccine AstraZeneca): safety signalSafety signalMedicine safety communications
19 July 2021EMAComirnaty / Spikevax (previously COVID-19 Vaccine Moderna): safety signalSafety signalMedicine safety communications
19 July 2021EMAJcovden (previously COVID-19 Vaccine Janssen): safety signalSafety signalMedicine safety communications